Zoledronate Administration Lowers Vertebral Fracture Incidence in Younger Postmenopausal Women Lacking Osteoporosis - Top-Institutions - MDSpire

Zoledronate Administration Lowers Vertebral Fracture Incidence in Younger Postmenopausal Women Lacking Osteoporosis

By
Christian Hannah
Jason T. Alexander
Samuel W. Trump
April 27, 2026
0 min

Journal Of General Internal Medicine (Springer)

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

#1

Mayo Clinic

Rochester, MN
Key Differentiators
- Endocrinology
- Metabolic Bone Disease
- Osteoporosis Research
#2

Massachusetts General Hospital

Boston, MA
Key Differentiators
- Endocrinology
- Bone Biology
- Clinical Trials in Osteoporosis
#3

University of California, San Francisco (UCSF) Medical Center

San Francisco, CA
Key Differentiators
- Endocrinology
- Osteoporosis
- Bone Metabolism
#4

University of Cambridge, MRC Epidemiology Unit

Cambridge, UK
Key Differentiators
- Epidemiology
- Bone Health
- Fracture Prevention
#5

University of Auckland, Liggins Institute

Auckland, New Zealand
Key Differentiators
- Bone Biology
- Endocrinology
- Clinical Trials

Original Source(s)

Journal Of General Internal Medicine (Springer)

Zoledronate Administration Lowers Vertebral Fracture Incidence in Younger Postmenopausal Women Lacking Osteoporosis

by Christian Hannah, Jason T. Alexander, Samuel W. Trump
April 27, 2026

Related Content

Frontiers In Endocrinology

Correction: Fracture and mortality outcomes by osteoporosis treatment route in patients with type 2 diabetes and obesity: a propensity-matched registry study

by Vanessa Rouach, Ohad Regev, Hilary Gortler, Yona Greenman, Gabriel Chodick, Inbal Goldshtein
May 12, 2026

Frontiers In Immunology

MiR-1a-3p/Fcgr4-dependent osteoclast activation regulates pathological bone loss

Frontiers In Surgery

Case Report: Tibial plateau fracture in Charcot neuroarthropathy: a report of two cases with contrasting outcomes

by Weikun Li, Yan Zhang, Hui Wang
May 28, 2026